tiprankstipranks
Lantheus Holdings Reports Strong 2024 Financial Performance
PremiumCompany AnnouncementsLantheus Holdings Reports Strong 2024 Financial Performance
29d ago
Lantheus: Strong Revenue Growth and Strategic Partnerships Justify Buy Rating
Premium
Ratings
Lantheus: Strong Revenue Growth and Strategic Partnerships Justify Buy Rating
29d ago
Lantheus reports Q4 adjusted EPS $1.59, consensus $1.54
Premium
The Fly
Lantheus reports Q4 adjusted EPS $1.59, consensus $1.54
30d ago
Lantheus backs FY24 adjusted EPS view $6.65-$6.70, consensus $6.75
PremiumThe FlyLantheus backs FY24 adjusted EPS view $6.65-$6.70, consensus $6.75
2M ago
Lantheus to acquire Evergreen Theragnostics for $250M upfront
Premium
The Fly
Lantheus to acquire Evergreen Theragnostics for $250M upfront
2M ago
Lantheus to Acquire Evergreen Theragnostics for $250 Million
Premium
Company Announcements
Lantheus to Acquire Evergreen Theragnostics for $250 Million
2M ago
Lantheus increases to 12.16% shareholding in Radiopharm Theranostics
PremiumThe FlyLantheus increases to 12.16% shareholding in Radiopharm Theranostics
3M ago
Radiopharm enters co-development partnership with Lantheus
Premium
The Fly
Radiopharm enters co-development partnership with Lantheus
3M ago
Lantheus Announces Departure of Chief Medical Officer
Premium
Company Announcements
Lantheus Announces Departure of Chief Medical Officer
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100